Profile
| Metric | Value |
|---|---|
| Full Name | The Clorox Company |
| Ticker | NYSE: CLX |
| Exchange | NYSE |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Country | United States |
| IPO | |
| Indexes | |
| Website | thecloroxcompany.com |
| Employees | 7,400 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $108.86 | |
| Price, 1D Change | +1.76% | |
| Market Cap | $13B | |
| TTM Dividend Yield | 4.52% | |
| PE Ratio | 17.06 | |
| Beta | 0.22 | |
| Revenue | $7B | |
| Revenue, 1Y Change | +0.16% | |
| EPS | $6.52 | |
| EPS, 1Y Change | +190.49% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $1.24 | |
| Next Ex-Dividend | $1.24 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $6.52 | |
| EPS Estimate | N/A | $5.98 |
| EPS Est. Change | N/A | -8.22% |
| Revenue | $7.10B | |
| Revenue Estimate | N/A | $6.49B |
| Revenue Est. Change | N/A | -8.61% |
| Current Price | $108.86 | |
| Price Target | - | $115.00 |
| Price Tgt. Change | - | +5.64% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.92 | $2.24 | -62.10% | |
| $7.06 | $6.52 | -7.69% | |
| $5.98 | N/A | -8.22% | |
| $6.75 | N/A | +3.55% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $7.15B | $7.09B | -0.82% | |
| $7.05B | $7.10B | +0.82% | |
| $6.49B | N/A | -8.61% | |
| $6.80B | N/A | -4.30% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -30.87% | |
| Price, 3Y | -25.49% | |
| Market Cap, 1Y | -31.53% | |
| Market Cap, 3Y | -26.40% | |
| Revenue, 1Y | +0.16% | |
| Revenue, 3Y | -0.04% | |
| EPS, 1Y | +190.49% | |
| EPS, 3Y | +74.79% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $108.86 | |
| SMA 200 | $121.44 | |
| SMA 200 vs Price | +11.56% | |
| SMA 50 | $103.46 | |
| SMA 50 vs Price | -4.96% | |
| Beta | 0.22 | |
| ATR | $2.36 | |
| 14-Day RSI | 69.36 | |
| 10-Day Volatility | 15.69% | |
| 1-Year Volatility | 23.39% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $1.24 | |
| Upcoming | $1.24 | |
| Dividend Yield | 4.48% | |
| Total Dividend | $4.88 | |
| Dividends Paid | $602.00M | |
| Payout Ratio | 73.06% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $7.10B | |
| EPS | $6.52 | |
| Gross Profit | $3.19B | |
| Gross Margin | 44.96% | |
| Operating Profit | $1.18B | |
| Operating Margin | 16.60% | |
| Net Income | $824.00M | |
| Net Margin | 11.60% | |
| EBITDA | $1.40B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 9.08 | |
| Current Ratio | 0.84 | |
| Quick Ratio | 0.57 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 3.59 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 17.06 | |
| PS Ratio | 1.96 | |
| PB Ratio | -603.58 | |
| EV/EBITDA | 13.09 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $321.00M | |
| Cash & Equivalents | $167.00M | |
| Total Assets | $5.56B | |
| Current Assets | $1.61B | |
| Total Liabilities | $5.08B | |
| Current Liabilities | $1.92B | |
| Total Debt | $2.92B | |
| Short Term Debt | $106.00M | |
| Accounts Payable | $838.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $6.29B | |
| Operating Expenses | $2.02B | |
| Cost Of Goods Sold | $3.91B | |
| SG&A | $0.00 | |
| D&A | $219.00M | |
| Interest Expense | $0.00 | |
| Income Tax | $254.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $981.00M | |
| CFI | -$94.00M | |
| CFF | -$924.00M | |
| Capex | $220.00M | |
| Free Cash Flow | $761.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Goldman Sachs | → | |
| Wells Fargo | → | |
| Citigroup | → | |
| Wells Fargo | → | |
| Morgan Stanley | → | |
| JP Morgan | → | |
| Citigroup | → | |
| JP Morgan | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with CLX
Data Sources & References
- CLX Official Website www.thecloroxcompany.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/21076/000002107625000053/0000021076-25-000053-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/21076/000002107625000039/0000021076-25-000039-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- CLX Profile on Yahoo Finance finance.yahoo.com/quote/CLX
- CLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/clx
FAQ
What is the ticker symbol for The Clorox Company?
The ticker symbol for The Clorox Company is NYSE:CLX
Does The Clorox Company pay dividends?
Yes, The Clorox Company pays dividends. The last payment was $1.24, with an ex-dividend date on October 22, 2025
What sector is The Clorox Company in?
The Clorox Company is in the Consumer Defensive sector
What industry is The Clorox Company in?
The Clorox Company is in the Household & Personal Products industry
What country is The Clorox Company based in?
The Clorox Company is headquartered in United States
When did The Clorox Company go public?
The Clorox Company initial public offering (IPO) was on March 21, 1983
Is The Clorox Company in the S&P 500?
Yes, The Clorox Company is included in the S&P 500 index
Is The Clorox Company in the NASDAQ 100?
No, The Clorox Company is not included in the NASDAQ 100 index
Is The Clorox Company in the Dow Jones?
No, The Clorox Company is not included in the Dow Jones index
When was The Clorox Company last earnings report?
The Clorox Company's most recent earnings report was on November 3, 2025
When does The Clorox Company report earnings?
The next expected earnings date for The Clorox Company is February 3, 2026
